• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Treatment outcomes of patients with tuberculosis in war affected region of Khyber Pakhtunkhwa, Pakistan.巴基斯坦开伯尔-普赫图赫瓦省战乱地区结核病患者的治疗效果。
BMC Infect Dis. 2020 Jul 1;20(1):463. doi: 10.1186/s12879-020-05184-3.
2
Treatment outcome of tuberculosis patients under directly observed treatment short course and its determinants in Shangla, Khyber-Pakhtunkhwa, Pakistan: A retrospective study.巴基斯坦开伯尔-普赫图赫瓦省尚拉地区直接督导下的短程治疗肺结核患者的治疗结果及其决定因素:一项回顾性研究
Int J Mycobacteriol. 2017 Oct-Dec;6(4):360-364. doi: 10.4103/ijmy.ijmy_69_17.
3
Predictors of poor treatment outcomes in multidrug-resistant tuberculosis patients: a retrospective cohort study.耐多药结核病患者不良治疗结局的预测因素:一项回顾性队列研究。
Clin Microbiol Infect. 2018 Jun;24(6):612-617. doi: 10.1016/j.cmi.2017.09.012. Epub 2017 Sep 29.
4
Molecular detection of rifampicin resistance by GeneXpert assay among treated and untreated pulmonary tuberculosis patients from Khyber Pakhtunkhwa, Pakistan.GeneXpert assay 对巴基斯坦开伯尔-普赫图赫瓦省治疗和未治疗的肺结核患者利福平耐药性的分子检测。
J Glob Antimicrob Resist. 2017 Jun;9:118-120. doi: 10.1016/j.jgar.2017.02.013. Epub 2017 May 10.
5
Treatment Delay among Pulmonary Tuberculosis Patients within the Pakistan National Tuberculosis Control Program.巴基斯坦国家结核病控制项目中肺结核患者的治疗延迟。
Am J Trop Med Hyg. 2018 Jul;99(1):143-149. doi: 10.4269/ajtmh.18-0001. Epub 2018 May 10.
6
Analysis of tuberculosis treatment outcomes among pulmonary tuberculosis patients in Bahawalpur, Pakistan.巴基斯坦巴哈瓦尔布尔肺结核患者的结核病治疗结果分析。
BMC Res Notes. 2018 Jun 8;11(1):370. doi: 10.1186/s13104-018-3473-8.
7
Treatment Outcome of Tuberculosis Patients under Directly Observed Treatment Short Course and Factors Affecting Outcome in Southern Ethiopia: A Five-Year Retrospective Study.埃塞俄比亚南部直接观察短程治疗下结核病患者的治疗结果及影响结果的因素:一项五年回顾性研究
PLoS One. 2016 Feb 26;11(2):e0150560. doi: 10.1371/journal.pone.0150560. eCollection 2016.
8
Determining treatment outcome of smear-positive pulmonary tuberculosis cases in Afar Regional State, Ethiopia: A retrospective facility based study.确定埃塞俄比亚阿法尔州涂片阳性肺结核病例的治疗结果:一项基于医疗机构的回顾性研究。
Int J Mycobacteriol. 2016 Jun;5(2):164-9. doi: 10.1016/j.ijmyco.2016.02.003. Epub 2016 Mar 5.
9
Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure.肺结核治愈后痰中仍存在存活结核分枝杆菌。
BMC Infect Dis. 2019 Oct 30;19(1):923. doi: 10.1186/s12879-019-4561-7.
10
Fifteen-year trend in treatment outcomes among patients with pulmonary smear-positive tuberculosis and its determinants in Arsi Zone, Central Ethiopia.埃塞俄比亚中部阿尔西地区痰涂片阳性肺结核患者治疗结果的15年趋势及其决定因素
Glob Health Action. 2014 Sep 19;7:25382. doi: 10.3402/gha.v7.25382. eCollection 2014.

引用本文的文献

1
Predicting Tuberculosis Incidence and Its Trend in Tigray, Ethiopia: A Reality-Counterfactual Modeling Approach.预测埃塞俄比亚提格雷地区的结核病发病率及其趋势:一种现实反事实建模方法。
Infect Drug Resist. 2024 Jul 26;17:3241-3251. doi: 10.2147/IDR.S464787. eCollection 2024.
2
Novel Mutations in MPT64 Secretory Protein of Complex.新型突变在复合 MPT64 分泌蛋白中。
Int J Environ Res Public Health. 2023 Jan 31;20(3):2530. doi: 10.3390/ijerph20032530.
3
Treatment outcomes and risk factors of death in childhood tuberculous meningitis in Kandahar, Afghanistan: a prospective observational cohort study.阿富汗坎大哈儿童结核性脑膜炎的治疗结果和死亡风险因素:一项前瞻性观察性队列研究。
Trans R Soc Trop Med Hyg. 2022 Dec 2;116(12):1181-1190. doi: 10.1093/trstmh/trac066.

本文引用的文献

1
Treatment outcome of tuberculosis treatment regimens in Kandahar, Afghanistan.阿富汗坎大哈的结核病治疗方案的治疗结果。
Indian J Tuberc. 2020 Jan;67(1):87-93. doi: 10.1016/j.ijtb.2018.10.008. Epub 2018 Nov 7.
2
Global Epidemiology of Tuberculosis and Progress Toward Achieving Global Targets - 2017.全球结核病流行病学和实现全球目标的进展——2017 年。
MMWR Morb Mortal Wkly Rep. 2019 Mar 22;68(11):263-266. doi: 10.15585/mmwr.mm6811a3.
3
Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.巴基斯坦开伯尔-普赫图赫瓦省结核分枝杆菌分离株中吡嗪酰胺耐药性及 pncA 基因突变。
BMC Infect Dis. 2019 Feb 6;19(1):116. doi: 10.1186/s12879-019-3764-2.
4
Analysis of tuberculosis treatment outcomes among pulmonary tuberculosis patients in Bahawalpur, Pakistan.巴基斯坦巴哈瓦尔布尔肺结核患者的结核病治疗结果分析。
BMC Res Notes. 2018 Jun 8;11(1):370. doi: 10.1186/s13104-018-3473-8.
5
Factors associated with tuberculosis treatment outcomes among tuberculosis patients attending tuberculosis treatment centres in 2016-2017 in Mogadishu, Somalia.2016 - 2017年在索马里摩加迪沙结核病治疗中心接受治疗的结核病患者中与结核病治疗结果相关的因素。
Pan Afr Med J. 2017 Nov 2;28:197. doi: 10.11604/pamj.2017.28.197.13439. eCollection 2017.
6
Treatment outcome of tuberculosis patients under directly observed treatment short course and its determinants in Shangla, Khyber-Pakhtunkhwa, Pakistan: A retrospective study.巴基斯坦开伯尔-普赫图赫瓦省尚拉地区直接督导下的短程治疗肺结核患者的治疗结果及其决定因素:一项回顾性研究
Int J Mycobacteriol. 2017 Oct-Dec;6(4):360-364. doi: 10.4103/ijmy.ijmy_69_17.
7
Factors Influencing Tuberculosis Treatment Outcome in Adult Patients Treated with Thrice-Weekly Regimens in India.印度采用每周三次治疗方案的成年肺结核患者治疗结果的影响因素
Antimicrob Agents Chemother. 2017 Apr 24;61(5). doi: 10.1128/AAC.02464-16. Print 2017 May.
8
Tuberculosis.肺结核。
Nat Rev Dis Primers. 2016 Oct 27;2:16076. doi: 10.1038/nrdp.2016.76.
9
Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study.乌兹别克斯坦新患结核病患者和既往治疗过的结核病患者治疗效果不佳的相关因素:一项为期五年的全国性研究。
PLoS One. 2015 Jun 15;10(6):e0128907. doi: 10.1371/journal.pone.0128907. eCollection 2015.
10
Prevalence of tuberculosis in Kotli, Azad Kashmir.克什米尔自由邦科特利的结核病患病率。
J Ayub Med Coll Abbottabad. 2013 Jan-Jun;25(1-2):175-8.

巴基斯坦开伯尔-普赫图赫瓦省战乱地区结核病患者的治疗效果。

Treatment outcomes of patients with tuberculosis in war affected region of Khyber Pakhtunkhwa, Pakistan.

机构信息

Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, 210009, China.

Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, 210009, China.

出版信息

BMC Infect Dis. 2020 Jul 1;20(1):463. doi: 10.1186/s12879-020-05184-3.

DOI:10.1186/s12879-020-05184-3
PMID:32611409
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC7329461/
Abstract

BACKGROUND

Globally, tuberculosis (TB) remains the leading cause of death from a single infectious disease. TB treatment outcome is an important indicator for the effectiveness of a national TB control program. This study aimed to assess treatment outcomes of TB patients and its determinants in Batkhela, Khyber Pakhtunkhwa, Pakistan.

METHODS

A retrospective cohort study was designed using all TB patients who were enrolled at District Head Quarter (DHQ) Hospital Batkhela, Pakistan, from January 2011 to December 2014. A binary logistic regression models were used to identify factors associated with successful TB treatment outcomes defined as the sum of cure and completed treatment.

RESULTS

A total of 515 TB patients were registered, of which 237 (46%) were males and 278 (53.98%) females. Of all patients, 234 (45.44%) were cured and 210 (40.77%) completed treatment. The overall treatment success rate was 444 (86.21%). Age 0-20 years (adjusted odds ratio, AOR = 3.47; 95% confidence interval, CI) = 1.54-7.81; P = 0.003), smear-positive pulmonary TB (AOR) = 3.58; 95% CI = 1.89-6.78; P = < 0.001), treatment category (AOR = 4.71; 95% CI = 1.17-18.97; P = 0.029), and year of enrollment 2012 (AOR = 6.26; 95% CI = 2.52-15.59; P = < 0.001) were significantly associated with successful treatment outcome.

CONCLUSIONS

The overall treatment success rate is satisfactory but still need to be improved to achieve the international targeted treatment outcome. Type of TB, age, treatment category, and year of enrollment were significantly associated with successful treatment outcomes.

摘要

背景

在全球范围内,结核病(TB)仍然是单一传染病导致死亡的主要原因。结核病治疗结果是国家结核病控制规划有效性的重要指标。本研究旨在评估巴基斯坦开伯尔-普赫图赫瓦省巴塔克赫拉的结核病患者的治疗结果及其决定因素。

方法

使用 2011 年 1 月至 2014 年 12 月在巴基斯坦巴塔克赫拉地区卫生署医院登记的所有结核病患者,设计了一项回顾性队列研究。使用二元逻辑回归模型确定与成功结核病治疗结果相关的因素,成功结核病治疗结果定义为治愈和完成治疗的总和。

结果

共登记了 515 名结核病患者,其中 237 名(46%)为男性,278 名(53.98%)为女性。所有患者中,234 人治愈(45.44%),210 人完成治疗(40.77%)。总体治疗成功率为 444 人(86.21%)。0-20 岁年龄组(调整后的优势比,AOR=3.47;95%置信区间,CI=1.54-7.81;P=0.003)、痰涂片阳性肺结核(AOR=3.58;95%CI=1.89-6.78;P<0.001)、治疗类别(AOR=4.71;95%CI=1.17-18.97;P=0.029)和 2012 年入组年份(AOR=6.26;95%CI=2.52-15.59;P<0.001)与治疗结果显著相关。

结论

总体治疗成功率令人满意,但仍需提高以实现国际目标治疗结果。结核病类型、年龄、治疗类别和入组年份与治疗结果显著相关。